The emerging landscape of breast cancer susceptibility
Stratton, Michael R, Rahman, Nazneen·2008·Nature Genetics
Cited by (487)
Items 101–200 of 487
- RNA Splicing: A New Player in the DNA Damage ResponseSilvia Carolina Lenzken, Alessia Loffreda, Silvia M.L. Barabino · 2013 · International Journal of Cell Biology
- Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndromeUffe Birk Jensen, Lone Sunde, Susanne Timshel, Britta Halvarsson, Anja Nissen, Inge Bernstein, Mef Christina Nilbert · 2009 · Breast Cancer Research and Treatment
- Understanding Susceptibility to Breast Cancer: From Risk Factors to Prevention StrategiesNatalia García‐Sancha, Roberto Corchado‐Cobos, Jesús Pérez‐Losada · 2025 · International Journal of Molecular Sciences
- Low-Frequency Coding Variants at 6p21.33 and 20q11.21 Are Associated with Lung Cancer Risk in Chinese PopulationsGuangfu Jin, Meng Zhu, Rong H. Yin, Wei Shen, Jia Liu, Jie Sun, Cheng Wang, Juncheng Dai, Hongxia Ma, Chen Hsuan Wu et al. · 2015 · The American Journal of Human Genetics
- Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer riskWei‐Yu Lin, Nicola J. Camp, Maya Ghoussaini, Jonathan Beesley, Kyriaki Michailidou, John Llewelyn Hopper, Carmel Apicella, Melissa C. Southey, Jennifer Stone, Marjanka K. Schmidt et al. · 2014 · Human Molecular Genetics
- Mutations in BRCA2 and taxane resistance in prostate cancerCathleen Nientiedt, Martina Heller, Volker Endris, Anna‐Lena Volckmar, Stefanie Zschäbitz, María Ángeles Tapia-Laliena, Anette U. Duensing, Dirk Jäger, Peter Schirmacher, Holger Sültmann et al. · 2017 · Scientific Reports
- Development of cancer genetic services in the UK: A national consultationIngrid Slade, Daniel Riddell, Clare Turnbull, Helen Hanson, Nazneen Rahman, for the MCG programme · 2015 · Genome Medicine
- Homozygous loss of function BRCA1 variant causing a Fanconi-anemia-like phenotype, a clinical report and review of previous patientsBruna Lucheze Freire, Thaís Kataoka Homma, Mariana F.A. Funari, Antônio Marcondes Lerário, A. Leal, Elvira Deolinda Rodrigues Pereira Velloso, Alexsandra Christianne Malaquias, Alexander A.L. Jorge · 2017 · European Journal of Medical Genetics
- Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test resultsJoël Vos, JC Oosterwijk, Encarna B. Gómez-García, Fred H. Menko, Am Jansen, Reinoud D. Stoel, Christie J. van Asperen, Aad Tibben, Anne Margarethe Stiggelbout · 2010 · Clinical Genetics
- MicroRNA signatures in hereditary breast cancerRosa Murria Estal, Sarai Palanca Suela, Inmaculada de Juan Jiménez, Cecilia M. Egoavil, Zaida García‐Casado, María José Juan-Fita, Ana Beatriz Sánchez‐Heras, Ángel Segura Huerta, Isabel Chirivella, Dolors Sánchez-Izquierdo et al. · 2013 · Breast Cancer Research and Treatment
- First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case reportCarla Barbara Ripamonti, Mara Colombo, Patrizia Mondini, Siranoush Manoukian, Bernard Peissel, Loris Bernard, Paolo Radice, Maria Luisa Carcangiu · 2013 · BMC Cancer
- Breast cancer susceptibility variants alter risks in familial diseaseAyşe Latif, Kristen D. Hadfield, Stephen A. Roberts, Andrew Shenton, Fiona I. Lalloo, Graeme Charles M. Black, Anthony Howell, D. Gareth Evans, William G. Newman · 2009 · Journal of Medical Genetics
- A Review of Breast Cancer Survivorship Issues from Survivors' PerspectivesJihyoung Cho, So‐Youn Jung, Jung Eun Lee, Eun‐Jung Shim, Nam Hyoung Kim, Zisun Kim, Guiyun Sohn, Hyun Jo Youn, Ku Sang Kim, Hanna Kim et al. · 2014 · Journal of Breast Cancer
- Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231Hamidreza Moazzeni, Ali Najafi, Marzieh Khani · 2017 · Molecular and Cellular Probes
- Population-based genetic testing for Women's cancer preventionOlivia Evans, Faiza Gaba, Ranjit Manchanda · 2020 · Best Practice & Research Clinical Obstetrics & Gynaecology
- Poly(ADP-ribose) binding and macroH2A mediate recruitment and functions of KDM5A at DNA lesionsRamhari Kumbhar, Anthony R. Sanchez, Jullian O. Perren, Fade Gong, David Corujo, Frank Medina, Sravan K. Devanathan, Blerta Xhemalçe, Andreas T. Matouschek, Marcus Buschbeck et al. · 2021 · The Journal of Cell Biology
- Molecular Analysis of the Breast Cancer Genes BRCA1 and BRCA2 Using Amplicon-Based Massive Parallel PyrosequencingGeneviève Michils, Silke Hollants, Luc Dehaspe, Jeroen Van Houdt, Yannick Bidet, Nancy A. Uhrhammer, Yves‐Jean Bignon, Joris Robert Vermeesch, Harry Cuppens, Gert Matthijs · 2012 · Journal of Molecular Diagnostics
- Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American populationLilian Jara S, Patricio González‐Hormazábal, Kerube Cerceño, Gabriella A. Di Capua, José Miguel Reyes, Rafael Blanco, Teresa Bravo, O Peralta, Fernando Gómez, Enrique Waugh et al. · 2012 · Breast Cancer Research and Treatment
- The power of DNA double‐strand break (DSB) repair testing to predict breast cancer susceptibilityMarlen Keimling, Miriam Deniz, Dominic Varga, Andreea Stahl, Hubert Schrezenmeier, R. Kreienberg, Isabell Hoffmann, J. König, Lisa Wiesmüller · 2012 · The FASEB Journal
- Oxidative stress in susceptibility to breast cancer: study in Spanish populationPatricia Rodrigues, Griselda de Marco, Jessica Furriol, María Luisa Mansego, Mónica Pineda-Alonso, Anna González‐Neira, Juan Carlos Martı́n-Escudero, Javier J. Benitez, Ana M. Lluch, Felipe Javier Chaves et al. · 2014 · BMC Cancer
- Risk factors for breast cancer in East Asian women relative to women in the WestChristine S PERRY, Jorge C OTERO, Jonathan L. Palmer, Annette S. Gross · 2009 · Asia-Pacific Journal of Clinical Oncology
- A Study on Genetic Variants of Fibroblast Growth Factor Receptor 2 (FGFR2) and the Risk of Breast Cancer from North IndiaSarah Siddiqui, Shilpi Chattopadhyay, Salman Akhtar, Mohammad Zeeshan Najm, S. V. S. Deo, N. K. Shukla, Syed Akhtar Husain · 2014 · PLoS ONE
- A Review of the Clinical Implications of Breast Cancer BiologyYekta Parsa, Seyed Abbas Mirmalek, Fatemeh Elham Kani, Amir Aidun, Seyed Alireza Salimi-Tabatabaee, Soheila Yadollah-Damavandi, Ehsan Jangholi, Tina Parsa, Ehsan Shahverdi · 2016 · Electronic physician
- Optimizing the identification of risk‐relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer familiesAnna Coppa, Arianna Nicolussi, Sonia D'inzeo, Carlo Capalbo, Francesca Belardinilli, Valeria Colicchia, Marialaura Petroni, Massimo Zani, Sergio Ferraro, Christian Rinaldi et al. · 2017 · Cancer Medicine
- PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancerPaolo Peterlongo, Irene Catucci, Graziella Pasquini, Paolo Verderio, Bernard Peissel, Monica Barile, Liliana Varesco, Mirko Riboni, Stefano Fortuzzi, Siranoush Manoukian et al. · 2010 · Breast Cancer Research and Treatment
- Rare Copy Number Variants Observed in Hereditary Breast Cancer Cases Disrupt Genes in Estrogen Signaling and TP53 Tumor Suppression NetworkKatri Pylkäs, Mikko Vuorela, Meeri Otsukka, Anne H. Kallioniemi, Arja Jukkola‐Vuorinen, Robert Winqvist · 2012 · PLoS Genetics
- The Korean Hereditary Breast Cancer Study: Review and Future PerspectivesEunyoung Kang, Sung‐Won Kim · 2013 · Journal of Breast Cancer
- Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2French Canadian families with high risk of breast cancerSylvie Desjardins, Joly Charles Beauparlant, Yvan Labrie, Geneviève Ouellette, INHERIT BRCAs, Francine Durocher · 2009 · BMC Cancer
- Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancerFatima Aloraifi, Michael R. Boland, Andrew Green, James Geraghty · 2015 · Surgical Oncology
- Mis‐splicing in breast cancer: identification of pathogenic BRCA2 variants by systematic minigene assaysEugenia Fraile-Bethencourt, Alberto Valenzuela-Palomo, Beatriz Díez-Gómez, Elisa Goina, A. Acedo, E. Buratti, E. Velasco · 2019 · Journal of Pathology
- Minigene Splicing Assays Identify 12 Spliceogenic Variants of BRCA2 Exons 14 and 15Eugenia Fraile‐Bethencourt, Alberto Valenzuela‐Palomo, Beatriz Díez‐Gómez, Marı́a J. Caloca, Susana Gómez‐Barrero, Eladio A. Velasco · 2019 · Frontiers in Genetics
- Unpacking the Blockers: Understanding Perceptions and Social Constraints of Health Communication in Hereditary Breast Ovarian Cancer (HBOC) Susceptibility FamiliesJune A. Peters, Regina H. Kenen, Lindsey M. Hoskins, Laura M. Koehly, Barry I. Graubard, Jennifer T. Loud, Mark H. Greene · 2011 · Journal of Genetic Counseling
- Exploring the short-term impact of DNA-testing in breast cancer patients: The counselees’ perception matters, but the actual BRCA1/2 result does notJoël Vos, Jan C. Oosterwijk, Encarna B. Gómez-García, Fred H. Menko, Margriet J Collee, Christie J. van Asperen, Anna Mai Jansen, Anne Margarethe Stiggelbout, Aad Tibben · 2011 · Patient Education and Counseling
- CHEK2 1100delC Is a Susceptibility Allele for HNPCC-Related Colorectal CancerMarijke Wasielewski, Hans F. A. Vasen, Juul Wijnen, Maartje J. Hooning, Dennis Dooijes, Carli M.J. Tops, Jan G.M. Klijn, Hanne E.J. Meijers-Heijboer, Mieke E. M. Schutte · 2008 · Clinical Cancer Research
- Low-risk susceptibility alleles in 40 human breast cancer cell linesMuhammad Ali Riaz, Fons Elstrodt, Antoinette Hollestelle, Abbas Dehghan, Jan G.M. Klijn, Mieke E. M. Schutte · 2009 · BMC Cancer
- Prevalence of the variant allele rs61764370 T>G in the 3′UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer familiesA. Hollestelle, Cory Pelletier, M. Hooning, E. Crepin, M. Schutte, M. Look, J. Collée, A. Nieuwlaat, L. Dorssers, C. Seynaeve et al. · 2010 · Breast Cancer Research and Treatment
- Phenotype-Genotype Correlation in Familial Breast CancerAna Cristina Vargas, Jorge Sergio Reis-Filho, Sunil R. Lakhani · 2011 · Journal of Mammary Gland Biology and Neoplasia
- Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American populationIsabel Elematore, Patricio González‐Hormazábal, José Miguel Reyes, Rafael Blanco, Teresa Bravo, O Peralta, Fernando Gómez, Enrique Waugh, Sonia Margarit, Gladys Ibañez et al. · 2014 · Molecular Biology Reports
- Joint Analysis of Multiple Traits Using "Optimal" Maximum Heritability TestZhenchuan Wang, Qiuying Sha, Shuanglin Zhang · 2016 · PLoS ONE
- Genome-wide Linkage Scan Reveals Three Putative Breast-Cancer-Susceptibility LociJuan Manuel Rosa-Rosa, Guillermo Pita, Miguel Urioste, Gemma Llort, Joan Brunet, Conxi Lázaro, Ignacio Blanco, Teresa Ramón y Cajal, Orland Dı́ez, Miguel de la Hoya et al. · 2009 · The American Journal of Human Genetics
- Functional Analysis of BARD1 Missense Variants in Homology-Directed Repair of DNA Double Strand BreaksCindy Lee, Tapahsama Banerjee, Jessica L. Gillespie, Amanda H. Ceravolo, Matthew R. Parvinsmith, Lea M. Starita, Stanley Fields, Amanda Ewart Toland, Jeffrey D. Parvin · 2015 · Human Mutation
- Association between breast cancer susceptibility loci and mammographic density: the Multiethnic CohortChristy G. Woolcott, Gertraud Maskarinec, Christopher A. Haiman, Martijn Verheus, Ian Pagano, Loı̈c Le Marchand, Brian E. Henderson, Laurence N. Kolonel · 2009 · Breast Cancer Research
- Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expressionJoel Anthony Smith, Martin L. Read, Jon Hoffman, Rachel Brown, Beth Bradshaw, Christopher Campbell, Trevor R. P. Cole, Johanna Dieguez Navas, Fiona Eatock, Justin S. Gundara et al. · 2016 · Human Molecular Genetics
- An overview of genetic services delivery for hereditary breast cancerSonya Reid, Lucy B. Spalluto, Katie Lang, Anne E. Weidner, Tuya Pal · 2022 · Breast Cancer Research and Treatment
- Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populationsDavid Barzan, Marlon Romano Veldwijk, Carsten Herskind, Yang Li, Bo Zhang, Elena Sperk, Wei‐Dong Du, Xue-Jun Zhang, Frederik K. Wenz · 2013 · European Journal of Human Genetics
- Short telomeres are frequent in hereditary breast tumors and are associated with high tumor gradeBeatriz Martínez–Delgado, Mercedes Gallardo, Miljana Tanić, Kira Yanowsky, Lucía Inglada‐Pérez, Alicia Barroso, Maria Socorro Rodriguez-Pinilla, Marta Cañamero, Marı́a A. Blasco, Javier J. Benitez · 2013 · Breast Cancer Research and Treatment
- Management of breast cancer--Part INicholas C. Turner, Alison Louise Jones · 2008 · BMJ
- Polymorphic variations in the FANCA gene in high‐risk non‐BRCA1/2 breast cancer individuals from the French Canadian populationNadhir Litim, Yvan Labrie, Sylvie Desjardins, Geneviève Ouellette, Karine V. Plourde, Pascal Belleau, INHERIT BRCAs, Francine Durocher · 2012 · Molecular Oncology
- Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in AsiansMi-Ryung Han, Wei Zheng, Qiuyin Cai, Yu-Tang Gao, Ying Zheng, Manjeet K. Bolla, Kyriaki Michailidou, Joe Dennis, Qin Wang, Alison M. Dunning et al. · 2017 · Carcinogenesis
- The emergence of human‐evolutionary medical genomicsBernard J. Crespi · 2010 · Evolutionary Applications
- Structure‐activity relationship of the peptide binding‐motif mediating the BRCA2:RAD51 protein–protein interactionDuncan E. Scott, May Marsh, Tom L. Blundell, Chris Abell, Marko Hyvönen · 2016 · FEBS Letters
- Family history and outcome of young patients with breast cancer in the UK (POSH study)BK Eccles, Ellen Copson, Ramsey Cutress, Tom Maishman, Douglas G. Altman, P Simmonds, S Gerty, Lorraine Durcan, Louise Stanton, Diana Eccles et al. · 2015 · British journal of surgery
- The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714predict adverse outcome for breast cancer patientsEydis Th. Gudmundsdottir, Rosa Bjork Barkardottir, Aðalgeir Arason, Haukur Gunnarsson, Laufey Thora Amundadottir, Bjarni Agnar Agnarsson, Oskar T. Johannsson, Inga Reynisdóttir · 2012 · BMC Cancer
- The BRCAness Landscape of CancerMaoni Guo, San Ming Wang · 2022 · Cells
- A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomasEmilia Wiecheć, Jens Overgaard, Lise Lotte Hansen · 2008 · Genes Chromosomes and Cancer
- The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesisBre‐Anne Fifield, Ingrid Qemo, Evie Kirou, Robert D. Cardiff, Lisa Ann Porter · 2019 · Breast Cancer Research
- Advancing personalized medicine: Integrating statistical algorithms with omics and nano-omics for enhanced diagnostic accuracy and treatment efficacyAbdurrahman Coşkun, Gökhan Ertaylan, Murih Pusparum, Rebekka Van Hoof, Zelal Zuhal Kaya, Arezoo Khosravi, Ali Zarrabi · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancerPriscilla H. Fernandes, Jennifer R. Saam, Jenny Peterson, Elisha Hughes, Rajesh Kaldate, Shelly Ann Cummings, Aaron P. Theisen, Sonia Chen, Jeffrey T. Trost, Benjamin B. Roa · 2014 · Cancer
- NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic ReviewFrancesco Berardinelli, Alessandra di Masi, Antonio Antoccia · 2013 · Current Genomics
- Associations of ATR and CHEK1 Single Nucleotide Polymorphisms with Breast CancerWei‐Yu Lin, Ian Wallace Brock, Dan Connley, Helen E. Cramp, Rachel M. Tucker, Jon Slate, Malcolm Reed, Sabapathy Prakash Balasubramanian, Lisa Cannon‐Albright, Nicola J. Camp et al. · 2013 · PLoS ONE
- Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment InteractionsAnja Schoeps, Anja Rudolph, Petra Seibold, Alison M. Dunning, Roger Laughlin Milne, Stig E. Bojesen, Anthony J. Swerdlow, Irene Louise Andrulis, Hermann Brenner, Sabine Behrens et al. · 2013 · Genetic Epidemiology
- Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic CarcinomaBin Liu, Yoshitsugu Mitani, Xiayu Rao, Mark Zafereo, Jianjun J. Zhang, Jianhua Zhang, P. Andrew Futreal, Guillermina Lozano, Adel K. El‐Naggar · 2017 · JNCI Journal of the National Cancer Institute
- Type II Transmembrane Serine Protease Gene Variants Associate with Breast CancerKaisa Luostari, Jaana M. Hartikainen, Maria Tengström, Jorma J. Palvimo, Vesa V Kataja, Arto Mannermaa, Veli‐Matti Kosma · 2014 · PLoS ONE
- A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancerEliseos J. Mucaki, Natasha Caminsky, Ami M. Perri, Ruipeng Lu, Alain Laederach, Matthew Halvorsen, Joan H.M. Knoll, Peter K. Rogan · 2016 · BMC Medical Genomics
- Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation statusMartin Nilsson, Linda Werner Hartman, Ingrid Idvall, Ulf Kristoffersson, Oskar T. Johannsson, Niklas Loman · 2014 · Breast Cancer Research and Treatment
- The biological age linked to oxidative stress modifies breast cancer aggressivenessMaría del Mar Sáez‐Freire, Adrián Blanco‐Gómez, Sonia Castillo‐Lluva, Aurora Gómez-Vecino, Julie Milena Galvis-Jiménez, Carmen Martín-Seisdedos, María Isidoro‐García, Lourdes Hontecillas‐Prieto, María Begoña García Cenador, Francisco Javier García‐Criado et al. · 2018 · Free Radical Biology and Medicine
- Genetic Variants in pre-miR-146a, pre-miR-499, pre-miR-125a, pre-miR-605, and pri-miR-182 Are Associated with Breast Cancer Susceptibility in a South American PopulationSebastián Morales, Tomas de Mayo, Felipe Gulppi, Patricio González‐Hormazábal, Valentina Carrasco, José Miguel Reyes, Fernando Gómez, Enrique Waugh, Lilian Jara S · 2018 · Genes
- Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signaturesWeston R. Bodily, Brian H. Shirts, Tom Walsh, Süleyman Gülsüner, Mary‐Claire King, Alyssa Parker, Moom Rahman Roosan, Stephen Piccolo · 2020 · PLoS ONE
- Screening for large genomic rearrangements in the FANCA gene reveals extensive deletion in a Finnish breast cancer familySzilvia Sólyom, Robert Winqvist, Jenni Nikkilä, Katrin Rapakko, Pasi P Hirvikoski, Hannaleena Kokkonen, Katri Pylkäs · 2011 · Cancer Letters
- BRCA1-Dependent Translational Regulation in Breast Cancer CellsEstelle Dacheux, Anne Vincent, Nicolas Nazaret, Christophe Combet, Anne Wierinckx, Sylvie Mazoyer, Jean‐Jacques Diaz, Joël Lachuer, Nicole Dalla Venezia · 2013 · PLoS ONE
- Evaluation of the Contribution of the Three Breast Cancer Susceptibility Genes CHEK2 , STK11 , and PALB2 in Non- BRCA1/2 French Canadian Families with High Risk of Breast CancerFrédéric Guénard, Christopher St-Laurent Pedneault, Geneviève Ouellette, Yvan Labrie, Jacques Simard, Francine Durocher · 2010 · Genetic Testing and Molecular Biomarkers
- Fertility preservation in BRCA mutation carriers—efficacy and safety issues: a reviewXiaofu Zhang, Jingxin Niu, Tuanjie Che, Yibei Zhu, Hongtao Zhang, Jing Qu · 2020 · Reproductive Biology and Endocrinology
- BRCA1: A Missing Link in the Fanconi Anemia/BRCA PathwayAlan D. D’Andrea · 2013 · Cancer Discovery
- Can Unknown Predisposition in Familial Breast Cancer be Family-Specific?Henry T. Lynch, Hongxiu Wen, Yeong C. Kim, Carrie Snyder, Yulia Kinarsky, Pei Xian Chen, Fengxia Xiao, David E. Goldgar, Kenneth H. Cowan, San Ming Wang · 2013 · The Breast Journal
- Epigenetic changes in BRCA1-mutated familial breast cancerBradley M. Downs, San Ming Wang · 2015 · Cancer Genetics
- Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancerXia Wang, Jamie K. Teer, Renee N. Tousignant, Albert M. Levin, David C. Boulware, Dhananjay Arun Chitale, Brandon M. Shaw, Zhihua Chen, Yonghong Zhang, Jaishri O'Neill Blakeley et al. · 2017 · Genes Chromosomes and Cancer
- Update on multi‐gene panel testing and communication of genetic test resultsSonya Reid, Tuya Pal · 2020 · The Breast Journal
- Hierarchical Modeling for Estimating Relative Risks of Rare Genetic Variants: Properties of the Pseudo-Likelihood MethodCapanu, Marinela, Begg, Colin B. · 2011 · Biometrics
- Breast Cancer Risk Assessment: Moving Beyond BRCA 1 and 2Jennifer Scalia Wilbur, Bradley L. Colins, Richard T. Penson, Don Steven Dizon · 2015 · Seminars in Radiation Oncology
- Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testingKim De Leeneer, Mieke Van Bockstal, Sara De Brouwer, Natalia Swietek, Peter Schietecatte, Nelly Sabbaghian, J Van den Ende, Sandra Willocx, Katrien Storm, Bettina Blaumeiser et al. · 2012 · Breast Cancer Research and Treatment
- Association between single-nucleotide polymorphisms in miRNA and breast cancer risk: an updated reviewTrinidad Arancibia, Sebastián Morales, Edio Maldonado, Lilian Jara S · 2021 · Biological Research
- Use of deep whole-genome sequencing data to identify structure risk variants in breast cancer susceptibility genesXingyi Guo, Jiajun Shi, Qiuyin Cai, Xiao‐Ou Shu, Jing He, Wanqing Wen, Jamie Allen, Paul D.P. Pharoah, Alison M. Dunning, David J Hunter et al. · 2018 · Human Molecular Genetics
- Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counselingMatilde Pensabene, Ilaria Spagnoletti, Ida Capuano, Caterina Condello, Stefano Pepe, Alma Contegiacomo, Giovanni Lombardi, Generoso Bevilacqua, Maria Adelaide Caligo · 2009 · Annals of Oncology
- Correlation between Lsp1 (Rs3817198) and Casc (Rs4784227) Polymorphisms and the Susceptibility to Breast CancerZahra Nourolahzadeh, Seyyed Masoud Houshmand, Fawzia Mostafa Mohammad, Saeid Ghorbian · 2020 · Reports of Biochemistry and Molecular Biology
- Mutation and association analysis of GEN1 in breast cancer susceptibilityClare Turnbull, Sarah T. Hines, Anthony Renwick, Deborah Hughes, David Pernet, Anna Elliott, Sheila Seal, Margaret Warren-Perry, D. Gareth Evans, Diana Eccles et al. · 2010 · Breast Cancer Research and Treatment
- Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancerAnna Tervasmäki, Robert Winqvist, Arja Jukkola‐Vuorinen, Katri Pylkäs · 2014 · BMC Cancer
- Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessmentJoël Vos, Fred H. Menko, Jan C. Oosterwijk, Christie J. van Asperen, Anne Margarethe Stiggelbout, Aad Tibben · 2012 · Psycho-Oncology
- MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumoursMiljana Tanić, E Andrés, Socorro Marıá Rodríguez-Pinilla, Iván Márquez‐Rodas, María Cebollero-Presmanes, María Victoria Fernández, Ana Osório, Javier J. Benitez, Beatriz Martínez–Delgado · 2013 · British Journal of Cancer
- Genetic Modifiers of the Breast Tumor MicroenvironmentMichael J. Flister, Carmen R. Bergom · 2018 · Trends in cancer
- Risks and Function of Breast Cancer Susceptibility AllelesSaeideh Torabi Dalivandan, Jasmine Plummer, Simon A. Gayther · 2021 · Cancers
- A global perspective on the ethnic-specific BRCA variation and its implication in clinical applicationSan Ming Wang · 2022 · Journal of the National Cancer Center
- A Multistage Association Study Identifies a Breast Cancer Genetic Locus at NCOA7Kathryn S.P. Higginbotham, Joan P. Breyer, Kevin M. Bradley, Peggy A. Schuyler, W. Dale Plummer, Marcia E. Freudenthal, Amy Trentham‐Dietz, Polly A. Newcomb, Melinda E. Sanders, David L. Page et al. · 2011 · Cancer Research
- Evaluation of Functional Genetic Variants for Breast Cancer Risk: Results From the Shanghai Breast Cancer StudyBo Zhang, Alicia C. Beeghly-Fadiel, Wei Lu, Qiuyin Cai, Yong-Bing Xiang, Ying Zheng, Jirong Long, Chuanzhong Ye, Kai Gu, Xiao Ou Shu et al. · 2011 · American Journal of Epidemiology
- A rare FANCA gene variation as a breast cancer susceptibility allele in an Iranian populationSakineh Abbasi, Mina Rasouli · 2017 · Molecular Medicine Reports
- Quinoline- and Benzoselenazole-Derived Unsymmetrical Squaraine Cyanine Dyes: Design, Synthesis, Photophysicochemical Features and Light-Triggerable Antiproliferative Effects against Breast Cancer Cell LinesEurico Lima, Renato E. Boto, Diana P. Ferreira, José Ramiro Fernandes, Paulo Almeida, L.F. Vieira Ferreira, Eliana B. Souto, Amélia Maria Silva, Lucinda Vaz Dos Reis · 2020 · Materials
- Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family RegistryEllen T. Chang, Roger Laughlin Milne, Kelly‐Anne Phillips, Jane C. Figueiredo, Meera Sangaramoorthy, Theresa H.M. Keegan, Irene Louise Andrulis, John Llewelyn Hopper, Pamela Jean Goodwin, Frances P. O’Malley et al. · 2008 · Breast Cancer Research and Treatment
- Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer familiesSzilvia Sólyom, Katri Pylkäs, Robert Winqvist · 2010 · Familial Cancer
- Exome Sequencing of Germline DNA from Non-BRCA1/2 Familial Breast Cancer Cases Selected on the Basis of aCGH Tumor ProfilingFlorentine Hilbers, Caro M. Meijers, Jeroen F. J. Laros, Michiel van Galen, Nicoline Hoogerbrugge, Hans F. A. Vasen, Petra M. Nederlof, Juul Wijnen, Christie J. van Asperen, Peter Devilee · 2013 · PLoS ONE
- Uncertainty related to multigene panel testing for cancer: a qualitative study on counsellors’ and counselees’ viewsNiki M. Medendorp, Marij A. Hillen, Laxsini Murugesu, Cora M. Aalfs, Anne Margarethe Stiggelbout, Ellen M. A. Smets · 2018 · Journal of Community Genetics
- Sequencing Analysis at 8p23 Identifies Multiple Rare Variants in DLC1 Associated with Sleep-Related Oxyhemoglobin Saturation LevelLiang, Jingjing, Cade, Brian E., He, Karen Y., Wang, Heming, Lee, Jiwon, Sofer, Tamar, Williams, Stephanie, Li, Ruitong, Chen, Han, Gottlieb, Daniel J. et al. · 2019 · The American Journal of Human Genetics